Research never stops

Archive



Dec 15, 2010

Metabolic disease alliance with MedImmune

Nov 23, 2010

Collaboration on neurological disease target with Merck KGaA

Nov 11, 2010

Accelerated Positive Trend on Evotec's Revenues and Profits

Oct 28, 2010

License and collaboration agreement with Jingxin Pharma for EVT 201

Oct 27, 2010

Pain Alliance with APEIRON Biologics

Oct 05, 2010

Evotec and Shionogi Enter Fragment-based Drug Discovery Alliance

Sep 23, 2010

Ion Channel Hit Identification Agreement with Almirall

Sep 02, 2010

Evotec Completes Acquisition of DeveloGen

Aug 12, 2010

Strong Milestone Income Leads to Profitable 1st Half

Aug 04, 2010

Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim received

Jul 14, 2010

Evotec acquires DeveloGen

Jul 01, 2010

EVT 101 Phase II study started

Jun 17, 2010

First Milestone in Oncology Programme with Boehringer Ingelheim

May 19, 2010

Clinical Trial Milestone achieved

May 12, 2010

Evotec's Drug Discovery Business Set for Strong Growth

May 10, 2010

Integrated Drug Discovery Alliance with Genentech

Apr 27, 2010

Research Grant for H3 Receptor Antagonist Programme

Mar 25, 2010

2009 Results: Significant Step towards Sustainability

Mar 23, 2010

M&A Advisor Global Healthcare Turnaround Company of the Year

Mar 18, 2010

Agreement with Hypha Discovery to Further Enhance Lead Identification Platform

Mar 11, 2010

High Throughput Screening Agreement with Active Biotech

Mar 10, 2010

Good Progress in Product Development in Treatment-Resistant Depression in its Alliance with Roche

Feb 25, 2010

Evotec Extends and Broadens Research Agreement with Cubist Pharmaceuticals

Feb 02, 2010

Evotec and Vifor Pharma Sign Major Cooperation Agreement

Jan 14, 2010

Evotec and CHDI Foundation, Inc. Extend Collaboration to Fight Huntington's Disease